Unihealth Hospitals (NSE:UNIHEALTH) Beta: N/A (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:UNIHEALTH Unihealth Hospitals Ltd NSE:UNIHEALTH
59 GF Score
Price ₹739.10
GF Value ₹385.86
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Unihealth Hospitals Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-24), Unihealth Hospitals's Beta is Not available.

Unihealth Hospitals  (NSE:UNIHEALTH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Unihealth Hospitals Beta Related Terms

Unihealth Hospitals Beta Historical Data

* Premium members only.

The historical data trend for Unihealth Hospitals's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unihealth Hospitals Beta Chart

Unihealth Hospitals Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Unihealth Hospitals Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:UNIHEALTH
59GF Score
Unihealth Hospitals Ltd NSE:UNIHEALTH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unihealth Hospitals Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Is Unihealth Hospitals (NSE:UNIHEALTH) Overvalued in 2026?

Based on GuruFocus' analysis, Unihealth Hospitals stock appears to be overvalued. The current stock price of ₹739.10 is trading 91.5% above its estimated GF Value™ of ₹385.86. GuruFocus considers Unihealth Hospitals to be Significantly Overvalued.

Key valuation signals for NSE:UNIHEALTH:

  • Beta: N/A
  • GF Value™: ₹385.86 vs. price of ₹739.10 (91.5% above fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the NSE:UNIHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unihealth Hospitals Business Description

Address 156 Tardeo Road, H-13 and H-14, Everest Building, Tardeo, Mumbai, MH, IND, 400034
Unihealth Hospitals Ltd is a healthcare service provider based out of India and has an operational presence in multiple countries across the African continent. The company is predominantly engaged in the business of medical tour operators, health consultancy services, and also trades in medical equipment. The company has only one reportable Business Segment, which is Healthcare Services and Trading in its related products. Geographically, the company derives revenue from India, Uganda, Tanzania, Nigeria, the UAE, and Mauritius.
59GF Score

Get the complete analysis for NSE:UNIHEALTH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹739.10
Price
₹385.86
GF Value